封面
市場調查報告書
商品編碼
1831933

犬異位性皮膚炎市場報告(按藥物類別、給藥途徑、配銷通路和地區分類)2025-2033

Canine Atopic Dermatitis Market Report by Drug Class Type, Route of Administration, Distribution Channel, and Region 2025-2033

出版日期: | 出版商: IMARC | 英文 150 Pages | 商品交期: 2-3個工作天內

價格

2024 年全球犬異位性皮膚炎市場規模達 24 億美元。展望未來, IMARC Group預計到 2033 年市場規模將達到 77 億美元,2025-2033 年期間的成長率 (CAGR) 為 13.1%。

犬異位性皮膚炎 (CAD) 是一種由花粉、屋塵、昆蟲叮咬、草和食物成分等過敏原引起的犬類過敏性皮膚病。它是一種遺傳性疾病,通常影響六個月至三歲的犬隻。它通常會影響動物的腹部、口腔、眼睛、趾間皮膚、耳廓、腕骨、肘部和會陰區域。 CAD 的特徵是各種症狀,例如過度抓癢、爪子、腋窩和臉部周圍發炎和搔癢。此病可以透過免疫抑制劑、單株抗體和糖皮質激素治療。這些藥物可以透過口服、注射和外用藥物給藥。已知它在德國牧羊犬、拉布拉多犬、黃金獵犬和哈巴狗中非常普遍。

犬異位性皮膚炎市場趨勢:

在全球範圍內,家養犬冠狀動脈疾病(CAD)發生率的上升是市場前景樂觀的關鍵因素之一。這可以歸因於不斷變化的環境條件、日益嚴重的空氣污染以及長期接觸過敏原。此外,寵物主人對CAD早期症狀和體徵(例如發紅、皮膚油膩和酵母味)的擔憂和認知日益加深,也推動了市場的成長。此外,單株抗體在治療CAD方面的廣泛應用也有利於市場的成長。這些抗體有助於引導所需的免疫反應,並抑制疾病的傳播。同時,致力於提供更優質動物照護的獸醫、醫院和診所數量不斷增加,也對市場成長產生了正面的影響。其他因素,包括政府推出的各項措施,限制在動物身上使用非處方人類藥物,以及獸醫領域的廣泛研發,預計將推動市場的成長。

本報告回答的關鍵問題:

  • 到目前為止,全球犬異位性皮膚炎市場表現如何,未來幾年又會如何表現?
  • COVID-19 對全球犬異位性皮膚炎市場有何影響?
  • 主要的區域市場有哪些?
  • 根據藥物類別,市場是如何分類的?
  • 根據行政路徑,市場如何分類?
  • 根據配銷通路,市場是如何分類的?
  • 該產業的價值鏈分為哪些階段?
  • 該行業的主要促進因素和挑戰是什麼?
  • 全球犬異位性皮膚炎市場的結構是怎麼樣的?主要參與者是誰?
  • 產業競爭程度如何?

目錄

第1章:前言

第2章:範圍與方法

  • 研究目標
  • 利害關係人
  • 資料來源
    • 主要來源
    • 二手資料
  • 市場評估
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第3章:執行摘要

第4章:簡介

第5章:全球犬異位性皮膚炎市場

  • 市場概況
  • 市場表現
  • COVID-19的影響
  • 市場預測

第6章:市場區隔:依藥品類別

  • 糖皮質激素
  • 免疫抑制劑
  • 單株抗體
  • 其他

第7章:市場區隔:依行政途徑

  • 外用
  • 口服
  • 注射劑

第8章:市場區隔:按配銷通路

  • 獸醫院
  • 寵物診所
  • 藥局和藥局
  • 其他

第9章:市場細分:依地區

  • 北美洲
    • 美國
    • 加拿大
  • 亞太
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 其他
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 俄羅斯
    • 其他
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他
  • 中東和非洲

第 10 章:SWOT 分析

第 11 章:價值鏈分析

第 12 章:波特五力分析

第13章:價格分析

第 14 章:競爭格局

  • 市場結構
  • 關鍵參與者
  • 關鍵參與者簡介
    • AB Science
    • Bimeda Inc.
    • Bioceltix SA
    • Boehringer Ingelheim International GmbH
    • Ceva Sante Animale
    • Dechra Pharmaceuticals PLC
    • Elanco Animal Health Incorporated
    • Phibro Animal Health Corporation
    • Toray Industries Inc.
    • Vetoquinol SA
    • Virbac
    • Zoetis Inc.
Product Code: SR112025A4700

The global canine atopic dermatitis market size reached USD 2.4 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 7.7 Billion by 2033, exhibiting a growth rate (CAGR) of 13.1% during 2025-2033.

Canine atopic dermatitis (CAD) is an allergic skin disease in dogs caused by allergens, such as pollens, house dust, insect bites, grass and food ingredients. It is an inherited predisposition that generally affects dogs aged between six months to three years. It commonly affects the ventral abdomen, mouth, eyes, interdigital skin, ear pinnae, carpal, elbow and perineal area of the animals. CAD is characterized by various symptoms, such as excessive scratching, inflammation and itching around paws, underarms and face. It can be treated by immuno-suppressants, monoclonal anatomy and glucocorticoids. They can be administered through oral, injectables and topical medications. It is known to be highly prevalent in German shepherds, Labradors, golden retrievers and pugs.

Canine Atopic Dermatitis Market Trends:

The increasing occurrence of CAD in domesticated dogs across the globe is one of the key factors creating a positive outlook for the market. This can be attributed to the changing environmental conditions, rising air pollution levels and prolonged exposure to allergens. Moreover, the increasing concerns and rising awareness among pet owners regarding early symptoms and signs of CAD, such as redness, greasy skin and yeasty smell, are providing a thrust to the market growth. Additionally, the widespread adoption of monoclonal antibodies for the treatment of the disease is favoring the market growth. These antibodies aid in directing the required immune response and calming the spread of the disease. In line with this, the increasing number of veterinary practitioners, hospitals and clinics dedicated to providing improved care for animals is positively impacting the market growth. Other factors, including the implementation of various government initiatives to restrict the usage of off-label human drugs on animals, along with extensive research and development (R&D) in the field of veterinary sciences, are anticipated to drive the market toward growth.

Key Market Segmentation:

Breakup by Drug Class Type:

  • Glucocorticoids
  • Immunosuppressants
  • Monoclonal Antibody
  • Others

Breakup by Route of Administration:

  • Topical
  • Oral
  • Injectable

Breakup by Distribution Channel:

  • Veterinary Hospitals
  • Pet Clinics
  • Pharmacies and Drugstores
  • Others

Breakup by Region:

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being AB Science, Bimeda Inc., Bioceltix SA, Boehringer Ingelheim International GmbH, Ceva Sante Animale, Dechra Pharmaceuticals PLC, Elanco Animal Health Incorporated, Phibro Animal Health Corporation, Toray Industries Inc., Vetoquinol S.A., Virbac and Zoetis Inc.

Key Questions Answered in This Report:

  • How has the global canine atopic dermatitis market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the global canine atopic dermatitis market?
  • What are the key regional markets?
  • What is the breakup of the market based on the drug class type?
  • What is the breakup of the market based on the route of administration?
  • What is the breakup of the market based on the distribution channel?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global canine atopic dermatitis market and who are the key players?
  • What is the degree of competition in the industry?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Canine Atopic Dermatitis Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Drug Class Type

  • 6.1 Glucocorticoids
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Immunosuppressants
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Monoclonal Antibody
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Others
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast

7 Market Breakup by Route of Administration

  • 7.1 Topical
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Oral
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Injectable
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast

8 Market Breakup by Distribution Channel

  • 8.1 Veterinary Hospitals
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Pet Clinics
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Pharmacies and Drugstores
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Others
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 AB Science
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
      • 14.3.1.3 Financials
    • 14.3.2 Bimeda Inc.
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
    • 14.3.3 Bioceltix SA
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
    • 14.3.4 Boehringer Ingelheim International GmbH
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
    • 14.3.5 Ceva Sante Animale
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
    • 14.3.6 Dechra Pharmaceuticals PLC
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
      • 14.3.6.3 Financials
    • 14.3.7 Elanco Animal Health Incorporated
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
      • 14.3.7.3 Financials
    • 14.3.8 Phibro Animal Health Corporation
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
      • 14.3.8.3 Financials
      • 14.3.8.4 SWOT Analysis
    • 14.3.9 Toray Industries Inc.
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
      • 14.3.9.3 Financials
      • 14.3.9.4 SWOT Analysis
    • 14.3.10 Vetoquinol S.A.
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
      • 14.3.10.3 Financials
    • 14.3.11 Virbac
      • 14.3.11.1 Company Overview
      • 14.3.11.2 Product Portfolio
      • 14.3.11.3 Financials
      • 14.3.11.4 SWOT Analysis
    • 14.3.12 Zoetis Inc.
      • 14.3.12.1 Company Overview
      • 14.3.12.2 Product Portfolio
      • 14.3.12.3 Financials
      • 14.3.12.4 SWOT Analysis

List of Figures

  • Figure 1: Global: Canine Atopic Dermatitis Market: Major Drivers and Challenges
  • Figure 2: Global: Canine Atopic Dermatitis Market: Sales Value (in Billion USD), 2019-2024
  • Figure 3: Global: Canine Atopic Dermatitis Market Forecast: Sales Value (in Billion USD), 2025-2033
  • Figure 4: Global: Canine Atopic Dermatitis Market: Breakup by Drug Class Type (in %), 2024
  • Figure 5: Global: Canine Atopic Dermatitis Market: Breakup by Route of Administration (in %), 2024
  • Figure 6: Global: Canine Atopic Dermatitis Market: Breakup by Distribution Channel (in %), 2024
  • Figure 7: Global: Canine Atopic Dermatitis Market: Breakup by Region (in %), 2024
  • Figure 8: Global: Canine Atopic Dermatitis (Glucocorticoids) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 9: Global: Canine Atopic Dermatitis (Glucocorticoids) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 10: Global: Canine Atopic Dermatitis (Immunosuppressants) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 11: Global: Canine Atopic Dermatitis (Immunosuppressants) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 12: Global: Canine Atopic Dermatitis (Monoclonal Antibody) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 13: Global: Canine Atopic Dermatitis (Monoclonal Antibody) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 14: Global: Canine Atopic Dermatitis (Other Drug Class Types) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 15: Global: Canine Atopic Dermatitis (Other Drug Class Types) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 16: Global: Canine Atopic Dermatitis (Topical) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 17: Global: Canine Atopic Dermatitis (Topical) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 18: Global: Canine Atopic Dermatitis (Oral) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 19: Global: Canine Atopic Dermatitis (Oral) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 20: Global: Canine Atopic Dermatitis (Injectable) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 21: Global: Canine Atopic Dermatitis (Injectable) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 22: Global: Canine Atopic Dermatitis (Veterinary Hospitals) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 23: Global: Canine Atopic Dermatitis (Veterinary Hospitals) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 24: Global: Canine Atopic Dermatitis (Pet Clinics) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 25: Global: Canine Atopic Dermatitis (Pet Clinics) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 26: Global: Canine Atopic Dermatitis (Pharmacies and Drugstores) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 27: Global: Canine Atopic Dermatitis (Pharmacies and Drugstores) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 28: Global: Canine Atopic Dermatitis (Other Distribution Channels) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 29: Global: Canine Atopic Dermatitis (Other Distribution Channels) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 30: North America: Canine Atopic Dermatitis Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 31: North America: Canine Atopic Dermatitis Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 32: United States: Canine Atopic Dermatitis Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 33: United States: Canine Atopic Dermatitis Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 34: Canada: Canine Atopic Dermatitis Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 35: Canada: Canine Atopic Dermatitis Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 36: Asia-Pacific: Canine Atopic Dermatitis Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 37: Asia-Pacific: Canine Atopic Dermatitis Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 38: China: Canine Atopic Dermatitis Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 39: China: Canine Atopic Dermatitis Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 40: Japan: Canine Atopic Dermatitis Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 41: Japan: Canine Atopic Dermatitis Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 42: India: Canine Atopic Dermatitis Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 43: India: Canine Atopic Dermatitis Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 44: South Korea: Canine Atopic Dermatitis Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 45: South Korea: Canine Atopic Dermatitis Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 46: Australia: Canine Atopic Dermatitis Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 47: Australia: Canine Atopic Dermatitis Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 48: Indonesia: Canine Atopic Dermatitis Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 49: Indonesia: Canine Atopic Dermatitis Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 50: Others: Canine Atopic Dermatitis Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 51: Others: Canine Atopic Dermatitis Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 52: Europe: Canine Atopic Dermatitis Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 53: Europe: Canine Atopic Dermatitis Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 54: Germany: Canine Atopic Dermatitis Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 55: Germany: Canine Atopic Dermatitis Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 56: France: Canine Atopic Dermatitis Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 57: France: Canine Atopic Dermatitis Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 58: United Kingdom: Canine Atopic Dermatitis Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 59: United Kingdom: Canine Atopic Dermatitis Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 60: Italy: Canine Atopic Dermatitis Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 61: Italy: Canine Atopic Dermatitis Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 62: Spain: Canine Atopic Dermatitis Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 63: Spain: Canine Atopic Dermatitis Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 64: Russia: Canine Atopic Dermatitis Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 65: Russia: Canine Atopic Dermatitis Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 66: Others: Canine Atopic Dermatitis Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 67: Others: Canine Atopic Dermatitis Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 68: Latin America: Canine Atopic Dermatitis Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 69: Latin America: Canine Atopic Dermatitis Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 70: Brazil: Canine Atopic Dermatitis Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 71: Brazil: Canine Atopic Dermatitis Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 72: Mexico: Canine Atopic Dermatitis Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 73: Mexico: Canine Atopic Dermatitis Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 74: Others: Canine Atopic Dermatitis Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 75: Others: Canine Atopic Dermatitis Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 76: Middle East and Africa: Canine Atopic Dermatitis Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 77: Middle East and Africa: Canine Atopic Dermatitis Market: Breakup by Country (in %), 2024
  • Figure 78: Middle East and Africa: Canine Atopic Dermatitis Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 79: Global: Canine Atopic Dermatitis Industry: SWOT Analysis
  • Figure 80: Global: Canine Atopic Dermatitis Industry: Value Chain Analysis
  • Figure 81: Global: Canine Atopic Dermatitis Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Canine Atopic Dermatitis Market: Key Industry Highlights, 2024 and 2033
  • Table 2: Global: Canine Atopic Dermatitis Market Forecast: Breakup by Drug Class Type (in Million USD), 2025-2033
  • Table 3: Global: Canine Atopic Dermatitis Market Forecast: Breakup by Route of Administration (in Million USD), 2025-2033
  • Table 4: Global: Canine Atopic Dermatitis Market Forecast: Breakup by Distribution Channel (in Million USD), 2025-2033
  • Table 5: Global: Canine Atopic Dermatitis Market Forecast: Breakup by Region (in Million USD), 2025-2033
  • Table 6: Global: Canine Atopic Dermatitis Market: Competitive Structure
  • Table 7: Global: Canine Atopic Dermatitis Market: Key Players